Bal Pharma to close down parenterals & IV fluids facility at Pune

Decision was taken as part of its restructuring exercise undertaken to streamline its operations

Premium

Bal Pharma's Pune unit

BS B2B Bureau Bengaluru

Last Updated : May 05 2017 | 2:29 PM IST

As part of its restructuring exercise, the Bengaluru-based pharmaceutical company Bal Pharma Ltd will shut down its parenterals and IV fluids manufacturing facility at Pune (Maharashtra).

“The company has decided to issue notice as per the provisions of Section 25 FFA read with Section 25 F of the Industrial Disputes Act, 1947, pertaining to its parenterals and IV fluids manufacturing facility at Pune. This decision was taken as part of the restructuring exercise undertaken by the company to streamline its operations and to exit from its noncore businesses, whose operational costs are significant but generate very nominal revenues,” said

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in